The UK government has proposed assuming direct control over the cost-effectiveness thresholds used by the National Institute for Health and Care Excellence (NICE), the body responsible for assessing the value of medicines and medical technologies. The proposal applies to both pharmaceuticals and medical devices. Under the proposal, responsibility for setting the threshold would move from NICE’s independent board to government…
Ben KempJanuary 5, 2026